 and bleeding risks
vary, individual judgment is required in the selection of
appropriate thrombolytic and concurrent anticoagulant
doses. Most would agree that thrombolytic infusion times
should be minimized and balanced against lytic progress to
avoid complications. Reimaging with follow-up venography at 8- to 24-hour intervals68 and discontinuation of
therapy once lytic stagnation is reached are commonly

JOURNAL OF VASCULAR SURGER